Effectiveness and impact of rotavirus vaccines in Europe, 2006-2014

Vaccine
Emilie KarafillakisChristina Atchison

Abstract

Prior to the introduction of rotavirus vaccines in 2006, rotavirus was the leading cause of severe gastroenteritis among European children <5 years of age. We conducted a systematic review of the published literature to examine the effectiveness and impact of rotavirus vaccines in Europe following the first eight years of routine use. Four publication databases were searched, yielding 276 unique citations from February 1st, 2006 to July 31st, 2014. Twenty four studies on effectiveness (n=9) and impact (n=15) met the inclusion criteria. Across Europe, vaccine effectiveness against rotavirus-related healthcare utilisation ranged from 68% to 98%, consistent with efficacy data from clinical trials. Reductions in rotavirus hospitalisations ranged from 65% to 84%, consistent with findings from post-marketing studies from the US and Latin America. We confirm the significant public health benefit of rotavirus vaccination in Europe and provide further evidence to support implementation of universal rotavirus vaccination in all European countries.

References

Jan 7, 2006·The Pediatric Infectious Disease Journal·Montse Soriano-GabarróThomas Verstraeten
Nov 26, 2009·The Pediatric Infectious Disease Journal·Maria Paulke-KorinekHerwig Kollaritsch
Jan 13, 2011·The Pediatric Infectious Disease Journal·Tessa BraeckmanPierre Van Damme
Mar 26, 2011·The Pediatric Infectious Disease Journal·Marc RaesBaudouin Standaert
Mar 30, 2011·Vaccine·Arnaud GagneurUNKNOWN IVANHOE investigators
Apr 28, 2011·Human Vaccines·Federico Martinón-TorresUNKNOWN ROTACOST research team
May 17, 2011·Vaccine·Germaine HanquetKoen Van Herck
Jul 1, 2011·Human Vaccines·Marta Bouzón AlejandroFederico Martinón-Torres
Sep 11, 2012·Human Vaccines & Immunotherapeutics·Sandra Dudareva-VizuleOle Wichmann
Oct 30, 2012·Vaccine·Juan B Bellido-BlascoM Rosario Moreno-Muñoz
Jan 22, 2013·The Pediatric Infectious Disease Journal·Cornelia AdlhochJudith Koch
Jul 10, 2013·Human Vaccines & Immunotherapeutics·Federico Martinón-TorresJose Maria Martinón-Sánchez
Jan 8, 2014·Expert Review of Vaccines·Brian RhaUmesh D Parashar
Apr 25, 2014·The Lancet Infectious Diseases·N ParezT Vesikari
Jul 30, 2014·Expert Review of Vaccines·Brian RhaUmesh D Parashar

❮ Previous
Next ❯

Citations

May 20, 2015·Pathogens·Nicholas M KiuliaJoan B Rose
Jan 9, 2016·The Journal of Infectious Diseases·Michael G Head, Benjamin A Lopman
Mar 15, 2016·The Pediatric Infectious Disease Journal·Tone BruunUNKNOWN Norwegian Enhanced Pediatric Immunisation Surveillance (NorEPIS) Network
Mar 17, 2016·Epidemiology and Infection·A S GastañaduyR E Bégué
Mar 19, 2016·Alimentary Pharmacology & Therapeutics·M UrbańskaH Szajewska
Apr 10, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gayane SahakyanMargaret M Cortese
Feb 5, 2015·Clinical and Experimental Vaccine Research·Bradford S PowellPeter C Fusco
May 18, 2016·The Journal of Infection·Irene Rivero-CalleFederico Martinón-Torres
Jul 28, 2016·Expert Review of Vaccines·Eliz Kilich, Manish Sadarangani
Dec 21, 2016·The Pediatric Infectious Disease Journal·Yury V LobzinNina V Tikunova
Apr 7, 2017·The Pediatric Infectious Disease Journal·Patricia Bruijning-Verhagen, Michelle Groome
Apr 12, 2017·Vaccine·Carl D KirkwoodA Duncan Steele
Apr 27, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christine L JonestellerUmesh D Parashar
May 27, 2017·Journal of Medical Virology·Diletta ValentiniMarina Monini
Nov 18, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Suifang YeKeith Grimwood
Dec 21, 2017·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Adnane LamraniSylvie Escolano
Aug 16, 2016·Canadian Journal of Public Health = Revue Canadienne De Santé Publique·Virginie GosselinMélissa Généreux
Oct 30, 2018·Infectious Diseases·A TilmanneC Quach
Feb 9, 2019·Human Vaccines & Immunotherapeutics·A D SteeleC D Kirkwood
Nov 23, 2019·Expert Review of Pharmacoeconomics & Outcomes Research·Nikolaos KotsopoulosBaudouin Standaert
Feb 9, 2017·The Pediatric Infectious Disease Journal·Hailing ChangMei Zeng
Jan 21, 2020·Pediatrics International : Official Journal of the Japan Pediatric Society·Mayumi OnoYukihiko Kawasaki
Jun 17, 2020·Expert Review of Vaccines·Benjamin D HallowellUmesh Parashar
Apr 10, 2017·Journal of the Pediatric Infectious Diseases Society·Victor S SantosRicardo Q Gurgel
Jul 12, 2017·BMC Pediatrics·Yoshiyuki FujiiTsutomu Takahashi
Aug 11, 2016·Indian Pediatrics·Joby JacobGagandeep Kang
May 15, 2018·Human Vaccines & Immunotherapeutics·Claudio CostantinoFrancesco Vitale
Aug 11, 2016·Indian Pediatrics·Anu PaulGagandeep Kang
Apr 10, 2019·Human Vaccines & Immunotherapeutics·Selim BadurDebasish Saha
Apr 16, 2019·Frontiers in Microbiology·Yoshiki FujiiKazuhiko Katayama
Jul 2, 2020·Vaccines·Olufemi Samuel Folorunso, Olihile M Sebolai

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.